The state of the art technique can improve hearing in children and adults with congenital deafness or severe hearing ...

By 2030, the cell and gene therapy market is projected to be worth £76.03bn, and logistics is essential in realising the ...

The state-of-the-art technique can improve hearing in children and adults with congenital deafness or severe hearing ...

ProBio opens a 128,000-sq.-ft. gene therapy facility in Hopewell, creating 110+ jobs and advancing global cell and gene ...

Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany ...

Sarepta Therapeutics said a second patient had died after receiving its $3.2 million gene therapy to treat Duchenne muscular ...

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and ...

ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today ...

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...

Medcare’s approach goes beyond clinical excellence. Patients benefit from a multidisciplinary team that includes experts in ...

How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and patient access?

At Miami-Dade’s public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a ...